Fields »
ABOUT
HELP
BLOG

379 GENES FOUND

Show / hide columns

XML | RDF | TSV | « prev | Page of 8 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
MC2RMelanocortin 2 receptor (adrenocorticotropic hormone)Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enriched
METMET proto-oncogene, receptor tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Plasma membrane
Cytosol		Mixed
MGAMMaltase-glucoamylaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enhanced
MMEMembrane metallo-endopeptidaseCancer-related genes
Candidate cardiovascular disease genes
CD markers
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
MMP14Matrix metallopeptidase 14 (membrane-inserted)Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Intermediate filaments
Cytosol		Mixed
MMP15Matrix metallopeptidase 15 (membrane-inserted)Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Plasma membrane
Cytosol		Tissue enhanced
MMP16Matrix metallopeptidase 16 (membrane-inserted)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Vesicles
Cytosol		Tissue enhanced
MMP24Matrix metallopeptidase 24 (membrane-inserted)Enzymes
FDA approved drug targets
Predicted membrane proteins
Nucleoli
Plasma membrane		Tissue enhanced
MPLMPL proto-oncogene, thrombopoietin receptorCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Plasma membraneTissue enhanced
MR1Major histocompatibility complex, class I-relatedFDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Plasma membraneMixed
MS4A1Membrane-spanning 4-domains, subfamily A, member 1CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Group enriched
MS4A2Membrane-spanning 4-domains, subfamily A, member 2FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
MTNR1AMelatonin receptor 1AFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
MTNR1BMelatonin receptor 1BFDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
NPC1L1NPC1-like 1FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
NPR1Natriuretic peptide receptor 1Enzymes
FDA approved drug targets
Predicted membrane proteins
Nucleus
Nucleoli
Plasma membrane		Tissue enhanced
NPR2Natriuretic peptide receptor 2Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Mixed
NTRK1Neurotrophic tyrosine kinase, receptor, type 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Vesicles
Cytosol		Tissue enriched
NTSR2Neurotensin receptor 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
OPRD1Opioid receptor, delta 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
OPRK1Opioid receptor, kappa 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
OPRM1Opioid receptor, mu 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
OXTROxytocin receptorFDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Tissue enriched
P2RY12Purinergic receptor P2Y, G-protein coupled, 12Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enriched
P2RY2Purinergic receptor P2Y, G-protein coupled, 2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
CytosolTissue enhanced
PDCD1Programmed cell death 1CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
PDE3APhosphodiesterase 3A, cGMP-inhibitedDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
CytosolTissue enhanced
PDGFRAPlatelet-derived growth factor receptor, alpha polypeptideCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Nucleus
Plasma membrane
Cell Junctions		Expressed in all
PDGFRBPlatelet-derived growth factor receptor, beta polypeptideCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Vesicles
Cytosol		Mixed
PLA2G6Phospholipase A2, group VI (cytosolic, calcium-independent)Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
RAS pathway related proteins
Microtubule organizing center
Cytosol		Expressed in all
PLAURPlasminogen activator, urokinase receptorCancer-related genes
CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membraneExpressed in all
PRLRProlactin receptorDisease related genes
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
PROS1Protein S (alpha)Candidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
PSMD1Proteasome 26S subunit, non-ATPase 1FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Nucleoplasm
Actin filaments		Expressed in all
PSMD2Proteasome 26S subunit, non-ATPase 2FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Expressed in all
PTGER1Prostaglandin E receptor 1 (subtype EP1), 42kDaFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced
PTGER2Prostaglandin E receptor 2 (subtype EP2), 53kDaFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
PTGER3Prostaglandin E receptor 3 (subtype EP3)FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
PTGER4Prostaglandin E receptor 4 (subtype EP4)FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Expressed in all
PTGFRProstaglandin F receptor (FP)FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
PTGIRProstaglandin I2 (prostacyclin) receptor (IP)FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
PTGISProstaglandin I2 (prostacyclin) synthaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Mixed
PTH2RParathyroid hormone 2 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
RAMP1Receptor (G protein-coupled) activity modifying protein 1FDA approved drug targets
Predicted membrane proteins
Nucleoplasm
Nuclear membrane		Tissue enhanced
RAMP2Receptor (G protein-coupled) activity modifying protein 2FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
VesiclesMixed
RAMP3Receptor (G protein-coupled) activity modifying protein 3FDA approved drug targets
Predicted membrane proteins
Tissue enhanced
RETRet proto-oncogeneCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Vesicles
Plasma membrane
Cytosol		Tissue enriched
RRM2Ribonucleotide reductase M2Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
CytosolMixed
RRM2BRibonucleotide reductase M2 B (TP53 inducible)Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Cytosol		Expressed in all
RYR1Ryanodine receptor 1 (skeletal)Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Golgi apparatus
Vesicles
Cytosol		Tissue enriched

« prev | Page of 8 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.